hydantoins has been researched along with T-Cell Lymphoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Czopek, A; Domínguez-Álvarez, E; Handzlik, J; Kaczor, A; Kieć-Kononowicz, K; Kincses, A; Kucwaj-Brysz, K; Latacz, G; Marć, MA; Nitek, W; Spengler, G; Szymańska, E; Żesławska, E | 1 |
| Ali, W; Battistelli, C; Dąbrowska, M; Handzlik, J; Honkisz-Orzechowska, E; Jacob, C; Kincses, A; Latacz, G; Nové, M; Rasile, MM; Romanelli, A; Spengler, G; Starek, M; Szymańska, E; Zwergel, C | 1 |
2 other study(ies) available for hydantoins and T-Cell Lymphoma
| Article | Year |
|---|---|
An insight into the structure of 5-spiro aromatic derivatives of imidazolidine-2,4-dione, a new group of very potent inhibitors of tumor multidrug resistance in T-lymphoma cells.
Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Humans; Imidazolidines; Lymphoma, T-Cell; Molecular Docking Simulation; Molecular Structure; Spiro Compounds; Structure-Activity Relationship | 2021 |
Discovery of phenylselenoether-hydantoin hybrids as ABCB1 efflux pump modulating agents with cytotoxic and antiproliferative actions in resistant T-lymphoma.
Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Drug Discovery; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Ethers; Hydantoins; Lymphoma, T-Cell; Mice; Molecular Structure; Organoselenium Compounds; Structure-Activity Relationship | 2020 |